Stephen Saad When Aspen Pharmacare made an agreement with J&J to make and sell its own generic Covid-19 vaccine much of the world rejoiced. Aspen CEO...
North Korea's admission that it is battling an "explosive" COVID-19 outbreak has raised concerns that the virus could devastate a country with an under-resourced...
At least one person confirmed to have COVID-19 has died in North Korea and hundreds of thousands have shown fever symptoms, state media said on Friday,...
The unprecedented rate of digital acceleration seen in the first two years of COVID-19 has set in train The post Pfizer: Pharma needs a business strategy...
Amid "Gravest COVID Emergency", North Korea Launches 3 Ballistic Missiles Ahead Of Biden Seoul Visit On Thursday North Korea continued its...
The United States will share technologies used to make COVID-19 vaccines through the World Health Organization and is working to expand rapid testing and...
Moderna Inc. has made all necessary submissions required by the U.S. Food and Drug Administration for emergency use authorization of the company's COVID-19...
MS patients treated with Rituximab have better responses to the COVID-19 vaccine if they have higher B cell counts. This is the finding of a study...
[Vienna, May 12, 2022] Researchers at the Complexity Science Hub Vienna (CSH) created a complete representation of Hungary’s economy. They mapped the...
Two political scientists in their study in South Dakota found people trusted medical professionals the least when it came to public health messages.
Inovio Pharmaceuticals announced a leadership change at the helm and the discontinuation of a Phase III COVID-19 vaccine study.
Funding: Medical Research Future Fund, mRNA Victoria, Jack Ma Foundation, IFM Investors, Australian Research Council and National Health and Medical Research...
Just as Emergent BioSolutions looked to be making some headway in course corrections following a production mishap that ruined millions of doses of Johnson...
J&J is turning to longtime insiders in the executive ranks to head up its consumer division, once the company completes its spinout: Thibaut Mongon,...
Current COVID-19 booster shots have a problem: they last only about four months and appear to have limited efficacy in a vaccinated population. Clearly,...
The healthcare sector offers a wide range of investment choices. Keep reading to learn more about investing in healthcare stocks. The post Investing in...
Joseph Kim, the longtime CEO who’s become almost synonymous with Inovio, is leaving the beleaguered company. Jacqueline Shea Stepping down to make room...
Danish drugmaker Novo Nordisk has traditionally generated its pipeline mainly from internal R&D, but a new alliance with The post Novo Nordisk forges...
Eight farming investments to buy provide fertile opportunities despite Russia’s President Vladimir Putin continuing its onslaught against Ukraine and...
Leftists Hate Free Speech Because They Fear Dissent, Not "Disinformation" Authored by Brandon Smith via Alt-Market.us, I think one of the...
Novavax Inc.'s shares plunged nearly 20 percent in premarket trading on May 10 due to uncertainty over global demand for the company's COVID-19 vaccine...
Not content with a $1.2 billion licensing deal for Biohaven Pharma’s oral migraine therapy rimegepant, Pfizer has just The post Pfizer upgrades Biohaven...
About four weeks before FDA’s outside advisors are slated to review Novavax’s Covid-19 jab after a long, federally-funded and winding journey that...
A team analyzed more than 21 million tweets about COVID-19 vaccines and found that negative sentiments on social media were tied to lower-than-expected...
Administering a fourth dose of an mRNA COVID-19 vaccine provides a stronger level of protection than a third The post COV-BOOST trial data show value of...
BioNTech continues to build on the success of the company's mRNA COVID-19 vaccine co-developed with Pfizer, rapidly expanding its investigational pipeline...
Japan Reports More Suspected Cases Of Unexplained Acute Hepatitis In Children Authored by Aldgra Fredly via The Epoch Times (emphasis ours), At...
In this GEN webinar, sponsored by Precision NanoSystems, our distinguished speaker, Dr. Ethan Settembre, will introduce us to the intricacies of saRNA...
Could these health care stocks be the remedy to investors’ recent stock market pains? The post Best Stocks To Buy Now? 5 Health Care Stocks In...
The Thai Food and Drug Administration will soon review trial results from its country’s first locally-developed Covid-19 vaccine, which uses the same...